AUSTER MARTIN (Chief Financial Officer) sold 37.0% of their position (28K shares) of VENTYX BIOSCIENCES, INC. on the open market
Open‑market sale worth $995.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/26/2023ACC: 0001209191-23-043460
Officer· Chief Financial Officer
Since Oct 2021
-28K
Net shares
Net seller
$995.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
28K acquired · 56K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+28K
Price / share
$3.45
Trade value
$96.60K
% of position
58.8%
7/25/2023
47.65K→75.65K
Common Stock
Direct
Shares
−28K
Price / share
$35.54
Trade value
$995.04K
% of position
37.0%
7/25/2023
75.65K→47.65K
Total
Net shares
+0.00
Net value
-$898.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/25/2023 | M · Option Exercise | +28K | $3.45 | $96.60K | 58.8% | 47.65K | 75.65K |
| Common Stock Direct | 7/25/2023 | S · Sale | −28K | $35.54 | $995.04K | 37.0% | 75.65K | 47.65K |
| Total | +0.00 | -$898.44K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
28K shares
Shares
−28K
Strike price
3.45
Held after
219.18K
Exercisable
—
7/25/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock28K shares | 7/25/2023 | M · Option Exercise | −28K | 3.45 | — | 219.18K |